Company intelligence / Profile preview

Metropolis Healthcare

Mumbai, Maharashtra, Indiametropolisindia.com ↗

Ownership: Private
Employees: ~4000
Development stage: Other

Overview

Metropolis Healthcare does not develop drugs or biologics. Its “pipeline” consists of its expanding menu of clinical laboratory tests and profiles. Metropolis offers over ~3,480 clinical laboratory tests and more than ~524 profiles covering prediction, early detection, screening, confirmation, monitoring across multiple disease areas. It conducts millions of tests annually with significant investment in specialized diagnostics including molecular genetics.

Therapeutic areas: Rare DiseasesInfectious DiseasesOncologyOtherCardiovascular
Modalities: Diagnostic testDeviceLaboratory-developed test (LDT)Small molecule
Industry: Pathology

Partnerships

National AIDS Control Organisation (NACO)various hospital networks

Beyond the preview

Go deeper on Metropolis Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Metropolis Healthcare.

Explore the full profile